When to omit lymphadenectomy during radical prostatectomy in patients with clinical localized prostate cancer: A clinical net benefit analysis weighting staging accuracy, risk of morbidity and life expectancy

Lignende værker

• A positive PSMA PET/CT Predicts more aggressive disease progression in patients with biochemical recurrence after radical prostatectomy
  af: L. Nocera, et al.
  Udgivet: (2020-10-01)
• A positive PSMA PET/CT predicts more aggressive disease progression in patients with biochemical recurrence after radical prostatectomy
  af: D. Robesti, et al.
  Udgivet: (2020-07-01)
• Association between BRCA 1/2 polymorphisms and disease aggressiveness in a prospective cohort of prostate cancer patients undergoing radical prostatectomy
  af: V. Cucchiara, et al.
  Udgivet: (2020-07-01)
• When to omit lymphadenectomy during radical prostatectomy in patients with clinical localized prostate cancer: A clinical net benefit analysis weighting staging accuracy, risk of morbidity and life expectancy
  af: A. Larcher, et al.
  Udgivet: (2020-07-01)
• Implementation of 4Kscore as a Secondary Test Before Prostate Biopsy: Impact on US Population Trends for Prostate Cancer
  af: Simone Scuderi, et al.
  Udgivet: (2023-06-01)